Based on these findings, we hypothesized that cholesteryl ester hydrolase activity promotes the emergence and growth of CRPC and other treatment-resistant forms of prostate cancer, a concept that has not been explored previously. This evidence concerns the gene CES1 and Familial prostate cancer.